In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor

Veterinary Research Communications

Volumn 35, Issue 6, 2011, Pages 391-399

  Nagamine, Marcia Kazumi ^a   Sanches, Daniel S ^a   Pinello, Katia C ^a   Torres, Luciana Neves ^a   Mennecier, Gregory ^a   Latorre, Andréia O ^a   Fukumasu, Heidge ^a   Zaidan Dagli, Maria Lucia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Canine mast cell tumor; Canine tumor; Histone deacetylase inhibitor; Mastocytoma; TrichostatinA; Tumor mast cell culture

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; TRICHOSTATIN A; TRYPAN BLUE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIPLOIDY; DOG; DRUG EFFECT; DRUG MECHANISM; FEMALE; IN VITRO STUDY; MASTOCYTOMA; NONHUMAN; TUMOR CELL CULTURE;

ACETYLATION; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOGS; FEMALE; HISTONE DEACETYLASE INHIBITORS; HISTONES; HYDROXAMIC ACIDS; MAST-CELL SARCOMA; MICE; MICE, NUDE; TETRAZOLIUM SALTS; THIAZOLES; TRYPAN BLUE;

CANIS FAMILIARIS;

EID: 80054905040     PISSN: 01657380     EISSN: 15737446     Source Type: Journal    
DOI: 10.1007/s11259-011-9474-x     Document Type: Article

References (21)

1. Andrade R, Crisol L, Prado R, Boyano MD, Arluzea J, Arechaga J (2010) Plasma membrane and nuclear envelope integrity during the blebbing stage of apoptosis: a time-lapse study. Biol Cell 102(1):25-35
2. Bloom F (1942) Spontaneous solitary and multiple mast cell tumors (mastocytoma) in dogs. Arch Pathol 33:661-676
3. Hong Z, Han Z, Xiao M, Yang Y, Xia X, Zhou J (2009) Microarray study of mechanism of trichostatin A inducing apoptosis of Molt-4 cells. J Huazhong Univ Sci Technolog Med Sci 29(4):445-450
4. Ishiguro T, Kadosawa T, Mori K, Takagi S, Okumura M, Fujinaga T (2001) Establishment and characterization of a new canine mast cell tumor cell line. J Vet Med Sci 63(9):1031-1034 (Pubitemid 33645096)
5. Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V (2004) The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41:371-377 (Pubitemid 39091026)
6. Krishnaswamy G, Ajitawi O, Chi DS (2006) The human mast cell-an overview. In: Krishnaswamy G, Chi DS (eds) Mast cells-methods and protocols. Humana, New Jersey, pp 13-34
7. Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R (2005) Normal and oncogenic forms of the receptor tyrosine kinase kit. Stem Cells 23(1):16-43 (Pubitemid 40105289)
8. Lin TY, Fenger J, Murahari S, Bear MD, Kulp SK, Wang D, Chen CS, Kisseberth WC, London CA (2010) AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit. Blood 115:4217-4225
9. London CA, Seguin B (2003) Mast cell tumors in the dog. Vet Clin North Am Small Anim Pract 33(3):473-489 (Pubitemid 36798633)
10. Medina V, Edmonds B, Young GP, James R, Appleton S, Zalewski PD (1997) Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 57:3697-3707 (Pubitemid 27381212)
11. Mukhopadhyay NK, Weisberg E, Gilchrist D, Bueno R, Sugarbaker DJ, Jaklitsch MT (2006) Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. Ann Thorac Surg 81:1034-1042 (Pubitemid 43247683)
12. Nielsen SW, Cole CR (1958) Canine mastocytoma-a report of one hundred cases. Am J Vet Res 19:417-432
13. Patnaik AK, Ehler WJ, MacEwen EG (1984) Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 21(5):469-474
14. Pinello KC, Nagamine M, Silva TC, Matsuzaki P, Caetano HV, Torres LN, Fukumasu H, Avanzo JL, Matera JM, Dagli MLZ (2009) In vitro chemosensitivity of canine mast cell tumors grades II and III to all-trans-retinoic acid (ATRA). Vet Res Commun 33(6):581-588
15. Thamm DH, Mauldin EA, Vail DM (1999) Prednisone and vinblastine chemotherapy for canine mast cell tumor-41 cases (1992-1997). J Vet Intern Med 13(5):491-497
16. Tsuji N, Kobayashi M, Nagashima K, WakisakaY KK (1976) A new antifungal antibiotic, trichostatin. J Antibiot (Tokyo) 29(1):1-6
17. Vigushin DM, Ali S, Pace PE, Mirsaidi N, Ito K, Adcock I, Coombes RC (2001) Trichostatin A is a histone deacetylase inhibitor wirh potent antitumor activity against breast câncer in vivo. Clin Cancer Res 7(4): 971-976 (Pubitemid 32708736)
18. Wetzel M, Premkumar DR, Arnold B, Pollack IF (2005) Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis. J Neurosurg 103(6 Suppl):549-556 (Pubitemid 44954878)
19. Yee SB, Kim MS, Baek SJ, Kim GC, Yoo KS, Yoo YH, Park BS (2004) Trichostatin A induces apoptosis of p815 mastocytoma cells in histone acetylation-and mitochondria-dependent fashion. Int J Oncol 25 (5):1431-1436
20. Yoshida M, Kijima M, Akita M, Beppu T (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265:17174-17179
21. Zemke D, Yamini B, Yuzbasiyan-Gurkan V (2002) Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Vet Pathol 39:529-535